| |
Geometric mean (%CV) |
Ratio A / B
(95% CI) |
p-value |
|
| Group A - CF |
Group B – healthy controls |
|
| Fibrinogen [G/L] |
3.93 (21.9%) |
3.00 (13.6%) |
1.31 (1.16, 1.49) |
0.0004 |
| CXCL8 [PG/ML] |
10.2 (66.1%) |
5.9 (81.6%) |
1.74 (1.14, 2.66) |
0.0065 |
| CC–16 [NG/ML] |
4.60 (42.9%) |
5.78 (28.7%) |
0.80 (0.64, 0.99) |
0.0760 |
| CXCL1 [PG/ML] |
47.3 (38.3%) |
40.5 (41.6%) |
1.17 (0.91, 1.50) |
0.0782 |
| SP–D [NG/ML] |
110 (38.6%) |
80 (63.3%) |
1.37 (1.02, 1.85) |
0.0954 |
| MMP9 [NG/ML] |
299 (67.7%) |
190 (88.4%) |
1.57 (1.02, 2.44) |
0.1250 |
|
